StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.00 (0.00%)

Close on Nov 18, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 5M, up 64.5% from the year before. The highest annual figure on record is 5M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20255M+64.5%
FY2024Dec 31, 20243M+45.3%
FY2023Dec 31, 20232M+33.9%
FY2022Dec 31, 20221M+35.3%
FY2021Dec 31, 20211M–

More XORTX Therapeutics figures

See a number that looks wrong?